Vetter has opened a new sales office at the Illinois Science + Technology Park in Skokie, IL, home of its first U.S. manufacturing facility. The office will be managed by Troy Carpenter, who was appointed as president of Vetter Pharma International USA Inc. The new office replaces its Yardley, PA sales office, founded in 1983 as Vetter Pharma-Turm Inc.

In a company statement, Vetter noted that the Midwest region is an emerging “hotspot” in biotechnology, and that the new office will help push business growth in North America. The manufacturing facility in Skokie — an expansion of Vetter Development Service — is scheduled to be operational in the beginning of 4Q10.

Mr. Carpenter will manage Vetter key account managers across the U.S. who are responsible for all sales and business development activities in North America. Previously, Mr. Carpenter was director, Key Account Management for Sartorius-Stedim Biotech. He also acted as key account manager for Vetter Pharma-Turm from 2002 to 2007, with responsibility for sales and business development in the U.S. western region.

“We are very pleased to have Troy rejoin Vetter as our new president of Vetter Pharma International USA Inc.,” said Peter Soelkner, Vetter managing director. “Troy’s extensive knowledge of the U.S. pharmaceutical and biotechnology markets is a tremendous asset to Vetter and will complement our key account management concept of working with clients from early development through commercial manufacturing and global market supply. Additionally, Troy’s previous work with companies in our industry clearly demonstrates his ability to successfully develop and execute sales strategies and manage account teams for top-tier companies.”